Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAFV600E dual inhibitors
Lamya H. Al-Wahaibi, Ahmed M. Gouda, Ola F. Abou‐Ghadir, et al.
Bioorganic Chemistry (2020) Vol. 104, pp. 104260-104260
Closed Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Globally Approved EGFR Inhibitors: Insights into Their Syntheses, Target Kinases, Biological Activities, Receptor Interactions, and Metabolism
Mohammed A. S. Abourehab, Alaa M. Alqahtani, Bahaa G. M. Youssif, et al.
Molecules (2021) Vol. 26, Iss. 21, pp. 6677-6677
Open Access | Times Cited: 125
Design, synthesis, and biological evaluation of novel EGFR inhibitors containing 5-chloro-3-hydroxymethyl-indole-2-carboxamide scaffold with apoptotic antiproliferative activity
Fatma A. Mohamed, Hesham A. M. Gomaa, Omnia M. Hendawy, et al.
Bioorganic Chemistry (2021) Vol. 112, pp. 104960-104960
Closed Access | Times Cited: 59
Optimization and SAR investigation of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as EGFR and BRAFV600E dual inhibitors with potent antiproliferative and antioxidant activities
Hesham A. M. Gomaa, Mohamed E. Shaker, Sami I. Alzarea, et al.
Bioorganic Chemistry (2022) Vol. 120, pp. 105616-105616
Closed Access | Times Cited: 44
Discovery of new pyrimido[5,4-c]quinolines as potential antiproliferative agents with multitarget actions: Rapid synthesis, docking, and ADME studies
Ramadan Ahmed Mekheimer, Samar M R Allam, Mariam A. Al‐Sheikh, et al.
Bioorganic Chemistry (2022) Vol. 121, pp. 105693-105693
Closed Access | Times Cited: 39
Therapeutic strategies of dual-target small molecules to overcome drug resistance in cancer therapy
Jing Ye, Junhao Wu, Bo Liu
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188866-188866
Closed Access | Times Cited: 25
Synthesis, Biological Evaluation, and Molecular Docking of Novel Azolylhydrazonothiazoles as Potential Anticancer Agents
Jehan Y. Al‐Humaidi, Sobhi M. Gomha, Sayed M. Riyadh, et al.
ACS Omega (2023) Vol. 8, Iss. 37, pp. 34044-34058
Open Access | Times Cited: 22
Design and Synthesis of New Dihydropyrimidine Derivatives with a Cytotoxic Effect as Dual EGFR/VEGFR-2 Inhibitors
Lamya H. Al-Wahaibi, Ali M. Elshamsy, Taha F. S. Ali, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34358-34369
Open Access | Times Cited: 9
Benzimidazole-Based Derivatives as Apoptotic Antiproliferative Agents: Design, Synthesis, Docking, and Mechanistic Studies
Bahaa G. M. Youssif, Martha M. Morcoss, Stefan Bräse, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 446-446
Open Access | Times Cited: 8
Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV
Heba A. Hofny, Mamdouh F. A. Mohamed, Hesham A. M. Gomaa, et al.
Bioorganic Chemistry (2021) Vol. 112, pp. 104920-104920
Closed Access | Times Cited: 52
Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives bearing 1,3-thiazole moiety as novel anti-inflammatory EGFR inhibitors with cardiac safety profile
Salah A. Abdel‐Aziz, Ehab S. Taher, Ping Lan, et al.
Bioorganic Chemistry (2021) Vol. 111, pp. 104890-104890
Closed Access | Times Cited: 47
New 1,3,4‐oxadiazoles linked with the 1,2,3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 6
Closed Access | Times Cited: 35
Structure-based design, synthesis and antiproliferative action of new quinazoline-4-one/chalcone hybrids as EGFR inhibitors
Mohamed Hisham, Heba A. Hassan, Hesham A. M. Gomaa, et al.
Journal of Molecular Structure (2022) Vol. 1254, pp. 132422-132422
Closed Access | Times Cited: 33
Novel piperine-carboximidamide hybrids: design, synthesis, and antiproliferative activity via a multi-targeted inhibitory pathway
Lamya H. Al-Wahaibi, Mohamed A. Mahmoud, Yaser A. Mostafa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 376-386
Open Access | Times Cited: 27
A Concise Review on Recent Development of Indole Derivatives for Anticancer Activities
B. T. Sridhar, Nagesh Gunavanthrao Yernale, Ramesh S. Gani, et al.
Journal of the Indian Chemical Society (2024) Vol. 101, Iss. 10, pp. 101282-101282
Closed Access | Times Cited: 6
Epidermal Growth Factor Receptors Unveiled: A Comprehensive Survey on Mutations, Clinical Insights of Global Inhibitors, and Emergence of Heterocyclic Derivatives as EGFR Inhibitors
Chandramouli Manojmouli, T. Y. Pasha, Mohamed Rahamathulla, et al.
Journal of drug targeting (2025), pp. 1-19
Closed Access
Design, Synthesis, and Antiproliferative Activity of Novel Indole/1,2,4-Triazole Hybrids as Tubulin Polymerization Inhibitors
Esraa Mahmoud, Dalia Abdelhamid, Anber F. Mohammed, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 275-275
Open Access
New antiproliferative 1,3,4-oxadiazole/benzimidazole derivatives: Design, synthesis, and biological evaluation as dual EGFR and BRAFV600E inhibitors
Fatma Fouad Hagar, Samar H. Abbas, Ahmed M. Sayed, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108297-108297
Closed Access
Design and synthesis of new triarylimidazole derivatives as dual inhibitors of BRAFV600E/p38α with potential antiproliferative activity
Bahaa G. M. Youssif, Ahmed M. Gouda, Amr H. Moustafa, et al.
Journal of Molecular Structure (2021) Vol. 1253, pp. 132218-132218
Closed Access | Times Cited: 38
Diketopiperazine Gels: New Horizons from the Self-Assembly of Cyclic Dipeptides
Marco Scarel, Silvia Marchesan
Molecules (2021) Vol. 26, Iss. 11, pp. 3376-3376
Open Access | Times Cited: 36
A comprehensive review of recent advances in the biological activities of 1,2,4‐oxadiazoles
Omnia M. Hendawy
Archiv der Pharmazie (2022) Vol. 355, Iss. 7
Closed Access | Times Cited: 23
Design and synthesis of new thiazolidinone/uracil derivatives as antiproliferative agents targeting EGFR and/or BRAFV600E
Mohammed B. Alshammari, Ashraf A. Aly, Bahaa G. M. Youssif, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 23
Synthesis and Biological Evaluation of Indole-2-Carboxamides with Potent Apoptotic Antiproliferative Activity as EGFR/CDK2 Dual Inhibitors
Lamya H. Al-Wahaibi, Yaser A. Mostafa, Mostafa Abdelrahman, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 1006-1006
Open Access | Times Cited: 22
Design, Synthesis, and Antiproliferative Activity of New 5-Chloro-indole-2-carboxylate and Pyrrolo[3,4-b]indol-3-one Derivatives as Potent Inhibitors of EGFRT790M/BRAFV600E Pathways
Lamya H. Al-Wahaibi, Anber F. Mohammed, Mostafa Abdelrahman, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1269-1269
Open Access | Times Cited: 14
Visible-Light-Induced α,γ-C(sp3)–H Difunctionalization of Piperidines
Biao Wang, Min‐Jie Zhou, Qi‐Lin Zhou
Organic Letters (2022) Vol. 24, Iss. 15, pp. 2894-2898
Closed Access | Times Cited: 19
A comprehensive review of recent advances in the biological activities of quinazolines
Hesham A. M. Gomaa
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 5, pp. 639-655
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top